Carnitine conjugates of adamantanamines derivatives as dual...

Details Carnitine conjugates of adamantanamines derivatives as dual... Carnitine conjugates of adamantanamines derivatives as dual...

2011-05-07

2011-11-01

Katakam, Sudhakar (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C514S626000, C514S511000

Reexamination Certificate

active

08049038

ABSTRACT:
This invention concerns compounds of adamantanamines and neramexane, including their pharmaceutically-acceptable salts, diesterioisomers, and formulations for treating Alzheimer's related dementias, depression, AIDS related dementias, as antivirals, inflammatory diseases such as rheumatoid arthritis, and cerebral ischemia, hyperlipidemia, and diabetes.

REFERENCES:
patent: 7977511 (2011-07-01), Goel
patent: 2003/0114460 (2003-06-01), Hughes et al.
patent: 2005/0049312 (2005-03-01), Makovec et al.
Blair Jarvis and David P. Figgitt, “Mementine”, Drugs Aging 20(6), 465-476 (2003), Adis Data Information BV 2003.
Barry Reisberg, MD et al.,“Memantine in Moderate-to-Severe Alzheimer's Disease”, N Engl. J. of Med. 348, 1333-1341 (2003), Mass. Medical Society.
C. G. Parsons et al., Memantine is a Clinically Well Tolerated NMDA Receptor Antagonist—a Review of Preclinical Data, Neutopharmacology 38, 735-767 (1999).
Gordon K. Wilcock, “Memantine for the Treatment of Dementia”, The Lancet, Neurology 2, 503-505 (Aug. 2003).
A. Bianchetti et al., “Effects of Acetyl-L-carnitine in Alzheimer's Disease Pateients Unresponsive to AChE-I”, Curr. Med. Res. and Opinion 19(4), 350-353 (2003), Librapharm Ltd.
A. Spagnoli, MD et al., “Long-term Acetyl-L-carnitine Treatment in Alzheimer's Disease”, Neurology 41, 1726-1732 (1991).
J. David Leander et al., “N-Methyl-D-aspartic acid-induced Lethality in Mice:Selective Antagonism by Phenylcyclidine-like Drugs”, Brain Res. 448, 115-120 (1988), Elserier Sci.
C. G. Parsons et al., Neuropharmacology 34(10), 1239-1256 (1995), Elsevier Sci.

Affiliated with

Also associated with

Rating

Carnitine conjugates of adamantanamines derivatives as dual... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carnitine conjugates of adamantanamines derivatives as dual..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carnitine conjugates of adamantanamines derivatives as dual... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4299070